A key part of creating an individualized treatment plan is understanding exactly what each patient’s labs and specialized testing reveal. Tests like the rGCC or “GREEK” test help guide which therapies may best fit a patient’s needs and how their program should be structured. For some patients, this may include insulin potentiation therapy (IPT)—a method of delivering chemotherapy in a significantly lower dose than traditional approaches. By using targeted, low-dose administration, IPT is designe